MicroRNAs have been reported to play an important role in tumor development and progression by targeting oncogenes and tumor suppressors. miR-23a has been described as significantly upregulated in multiple cancers and involved in tumorigenesis. The aim of this study was to evaluate the potential roles of miR-23a in pancreatic ductal adenocarcinoma (PDAC). We found that miR-23a level was significantly increased in tissues of PDAC compared with that in the control by real-time PCR. FOXP2 expression was downregulated and inversely correlated with miR-23a. miR-23a directly targeted the 3'-untranslated region of FOXP2 mRNA and repressed its expression. Mechanistically, enhancement of miR-23a by transfection with mimics in Aspc-1 cells significantly promoted cell proliferation and invasion, while miR-23a inhibitors transfection in SW1990 cells induced an inhibitory effect. Moreover, restoration of FOXP2 impaired the pro-proliferation and proinvasion effects of miR-23a, indicating FOXP2 is a direct mediator of miR-23a functions. In conclusion, our findings suggest a novel miR-23a/FOXP2 link contributing to PDAC development and invasion. It may be a potential diagnostic and therapeutic target for PDAC.
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|4 区医学
小类|3 区医学:内科4 区医学:研究与实验
最新[2025]版:
大类|4 区医学
小类|4 区医学:内科4 区医学:研究与实验
JCR分区:
出版当年[2016]版:
Q2MEDICINE, GENERAL & INTERNALQ3MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1MEDICINE, GENERAL & INTERNALQ3MEDICINE, RESEARCH & EXPERIMENTAL
第一作者单位:[1]Karamay Cent Hosp, Dept Gen Surg, Karamay, Xinjiang, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
Diao Hongliang,Ye Zhou,Qin Renyi.miR-23a acts as an oncogene in pancreatic carcinoma by targeting FOXP2[J].JOURNAL OF INVESTIGATIVE MEDICINE.2018,66(3):676-683.doi:10.1136/jim-2017-000598.
APA:
Diao, Hongliang,Ye, Zhou&Qin, Renyi.(2018).miR-23a acts as an oncogene in pancreatic carcinoma by targeting FOXP2.JOURNAL OF INVESTIGATIVE MEDICINE,66,(3)
MLA:
Diao, Hongliang,et al."miR-23a acts as an oncogene in pancreatic carcinoma by targeting FOXP2".JOURNAL OF INVESTIGATIVE MEDICINE 66..3(2018):676-683